Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 22% ± 7% | |
glutamatergic neuron | 3 studies | 29% ± 8% | |
oligodendrocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1675.46 | 1445 / 1445 | 100% | 19.82 | 183 / 183 |
lung | 100% | 2271.14 | 578 / 578 | 100% | 14.06 | 1155 / 1155 |
brain | 100% | 1099.50 | 2637 / 2642 | 100% | 17.29 | 705 / 705 |
breast | 100% | 1685.55 | 459 / 459 | 100% | 15.81 | 1114 / 1118 |
thymus | 100% | 1821.31 | 653 / 653 | 99% | 11.02 | 600 / 605 |
prostate | 100% | 1532.21 | 245 / 245 | 99% | 10.21 | 497 / 502 |
uterus | 100% | 1625.48 | 170 / 170 | 99% | 13.69 | 454 / 459 |
bladder | 100% | 1558.29 | 21 / 21 | 98% | 11.12 | 493 / 504 |
pancreas | 99% | 725.99 | 326 / 328 | 98% | 11.81 | 175 / 178 |
ovary | 100% | 1239.31 | 180 / 180 | 98% | 8.45 | 420 / 430 |
stomach | 100% | 1428.43 | 359 / 359 | 98% | 11.88 | 279 / 286 |
intestine | 100% | 1701.53 | 966 / 966 | 97% | 11.59 | 512 / 527 |
kidney | 100% | 1369.78 | 89 / 89 | 97% | 10.60 | 872 / 901 |
adrenal gland | 100% | 1300.88 | 258 / 258 | 96% | 9.42 | 220 / 230 |
skin | 100% | 1647.86 | 1807 / 1809 | 92% | 11.73 | 434 / 472 |
liver | 100% | 680.40 | 226 / 226 | 70% | 4.36 | 283 / 406 |
adipose | 100% | 1843.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1913.20 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.20 | 29 / 29 |
spleen | 100% | 1959.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.68 | 1 / 1 |
heart | 100% | 1157.43 | 858 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 951.47 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 1460.99 | 749 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 3.64 | 45 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0007175 | Biological process | negative regulation of epidermal growth factor-activated receptor activity |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0005515 | Molecular function | protein binding |
GO_0046935 | Molecular function | 1-phosphatidylinositol-3-kinase regulator activity |
Gene name | SOCS4 |
Protein name | Suppressor of cytokine signaling 4 (SOCS-4) (Suppressor of cytokine signaling 7) (SOCS-7) |
Synonyms | SOCS7 |
Description | FUNCTION: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. Substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Inhibits EGF signaling by mediating the degradation of the Tyr-phosphorylated EGF receptor/EGFR. . |
Accessions | ENST00000555846.2 ENST00000339298.2 Q8WXH5 ENST00000395472.2 |